Equity Research, Broker Reports, and media content on AstraZeneca

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about AstraZeneca
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on AstraZeneca. We currently have 92 research reports from 8 professional analysts.

Open
6821p
Range Today
6763/6860p
52 Week
5325/7533p
Daily Volume
1.3m
# Shares
1,312m
Daily Liquidity
(0.10%)
Pension Liability
£2,792m
Enterprise Value
£110,417m
Market Cap
£88,841m
Latest PE (hist)
16.66
Div Yield
3.82
Date Source Announcement
17Oct19 07:00 RNS Trastuzumab deruxtecan granted FDA Priority Review
04Oct19 15:04 RNS Holding(s) in Company
04Oct19 15:00 RNS Holding(s) in Company
04Oct19 07:00 RNS Fasenra approved in the US for self-administration
03Oct19 16:00 RNS Director Declaration
01Oct19 15:00 RNS Total Voting Rights
01Oct19 07:05 RNS AstraZeneca divests rights for Losec to Cheplaphar
  • Frequency of research reports

     

  • Research reports on

    AstraZeneca

  • Providers covering

    AstraZeneca